Lincoln Pharma reports 31% rise in net profit at Rs13.37cr in Q3FY21; stock trades higher

The healthcare companys net revenue for the Q3FY21 was reported at Rs113.26cr, higher by 15.56% over net revenue of Rs98.01cr in Q3FY20.

from India Infoline News Service https://ift.tt/36FdnPc